Clinical Trial Update: Impact of Clinician-administered Vaginal Live Biotherapeutic Product [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating a clinician-administered vaginal live biotherapeutic product for bacterial vaginosis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Vaginal Live Biotherapeutic Product (vaginal live biotherapeutic product)

Snippet

Sponsor: Caroline Mitchell | Conditions: Bacterial Vaginosis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING